We were fortunate to meet with MDS Congress Scientific Program Committee member, Antonio Strafella (Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada) who spoke to us about imaging biomarkers of cognitive decline in Parkinson’s disease.
1. What is known about the pathological processes underlying cognitive decline in Parkinson’s disease (PD)? (0:05)
2. What neuroimaging biomarkers appear useful in this setting? (1:40)
3. What are the most promising CSF biomarkers of cognitive decline in PD? (3:18)
4. What genetic factors affect the risk of cognitive decline in patients with PD? (4:17)
5. What further research is needed before these biomarkers enter clinical use? (5:44)
Speaker disclosure: Antonio P Strafella has received funding from the Canada Research Chairs Program (CRCP), Canadian Institutes of Health Research (CIHR), National Parkinson Foundation (NPF), Parkinson Disease Foundation (PDF), Parkinson Canada, Ontario Gambling Association, Tourette Syndrome Association (TSA), Brain Canada, Weston Brain Institute, and honoraria from GE Healthcare Canada Ltd.
Filmed at the International Congress of Parkinson’s Disease and Movement Disorders (MDS), Nice, France, September 2019.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson’s disease. He particularly focusses on new insights in early detection of the disease before motor symptoms […]
Highlights from EAN 2023!
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!